Residual treatment of Aedes aegypti (Diptera: Culicidae) in containers using Pyriproxyfen slow-release granules (Sumilarv 0.5G)

The residual efficacy of pyriproxyfen against Aedes aegypti (L.) was examined by treating 2-liter buckets with a range of rates of Sumilarv 0.5G (100, 10, 1, and 0.1 mg product/liter or nominal dose of 500, 50, 5, and 0.5 ppb active ingredient) under semifield conditions. Approximately every 2 wk, pupal emergence inhibition (EI) was measured by using Cairns colony Ae. aegypti. Pooled water samples from the five replicate buckets were analyzed for active pyriproxyfen by using ultra-high-pressure liquid chromatography with tandem mass spectrometry detection. A strong dose‐response in EI was exhibited, with the 0.1 mg/liter giving ≈50% EI for only the initial week, whereas the 10 and 100 mg/liter doses produced EI > 90% for 8 and 40 wk, respectively. Measurable levels of active ingredient were detected in the 100, 10, and 1 mg/liter treatments, with measured starting concentrations of just 1‐2‐1.4% of the delivered (active ingredient) dose. Pyriproxyfen was detected in the 100 mg/liter treatment through the entire course of the trial (60 wk)

The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific

We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis—a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries’ ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them

Development of the gravid Aedes trap for the capture of adult female container-exploiting mosquitoes (Diptera: Culicidae)

Monitoring dengue vector control by sampling adult Aedes aegypti (L.) recently has been used to replace both larval and pupal surveys. We have developed and evaluated the Gravid Aedes Trap (GAT) through a sequential behavioral study. The GAT does not require electricity to function, and trapped mosquitoes are identified easily during trap inspections. The GAT concept relies on visual and olfactory cues to lure gravid Ae. aegypti and an insecticide to kill trapped mosquitoes. Gravid mosquitoes are lured to a black bucket base containing oviposition attractant (infusion) and are trapped in a translucent chamber impregnated with a pyrethroid insecticide where they are killed within 3-15 min. In semifield observations, the GAT captured a significantly higher proportion of gravid mosquitoes than the double sticky ovitrap. We also demonstrated that the visual cues of the prototype GAT-LgBF (large black base bucket with a black funnel at the top of the translucent chamber) captured a significantly higher proportion of gravid mosquitoes than the other prototypes. The visual contrast created by the addition of a white lid to the top of the black funnel significantly increased the number of captured gravid mosquitoes when compared with the GAT-LgBF in semifield trials. We conclude that the GAT is more efficient in recapturing gravid Ae. aegypti when compared with sticky ovitraps. The GAT is an effective, practical, low cost, and easily transportable trap, features that are essential in large-scale monitoring programs, particularly in areas where funding is limited

Effects of sublethal exposure to metofluthrin on the fitness of Aedes aegypti in a domestic setting in Cairns, Queensland

Abstract Background Metofluthrin is highly effective at reducing biting activity in Aedes aegypti. Its efficacy lies in the rapid onset of confusion, knockdown, and subsequent kill of a mosquito. In the field, there are a variety of scenarios that might result in sublethal exposure to metofluthrin, including mosquitoes that are active at the margins of the chemical’s lethal range, brief exposure as mosquitoes fly in and out of treated spaces or decreasing efficacy of the emanators with time. Sublethal effects are key elements of insecticide exposure and selection. Methods The metofluthrin dose for each treatment group of male and female Ae. aegypti was controlled using exposure time intervals to a 10% active ingredient (AI) metofluthrin emanator. Room size and distance from the emanator for all groups was maintained at 3 m. In bioassay cages, male Ae. aegypti were exposed at 0, 5, 10, 20, 30 and 40-min intervals. Females were exposed in bioassay cages at 0, 10, 20, 30, 40 and 60-min intervals. Mortality rates and fecundity were observed between the exposure time groups for both sexes. Results Female Ae. aegypti exposed for 60 min had a significantly higher mortality rate (50%), after a 24-h recovery period, than other exposure times, 10, 20, 30 and 40 min (P  0.05). Conclusion Regardless of sex, if a mosquito survived exposure, it would be as biologically successful as its unexposed counterpart. Portability of the metofluthrin emanator and delayed knockdown effects create opportunities for sublethal exposure and potential pyrethroid resistance development in Ae. aegypti, and should be taken into consideration in recommendations for field application of this product, including minimum exposure periods and a prescribed number of emanators per room based on volume

Metofluthrin: investigations into the use of a volatile spatial pyrethroid in a global spread of dengue, chikungunya and Zika viruses

Abstract Background Metofluthrin reduces biting activity in Aedes aegypti through the confusion, knockdown, and subsequent kill of a mosquito. A geographical spread in dengue, chikungunya, and Zika viruses, increases intervention demands. Response to a Zika outbreak may require a different strategy than dengue, as high-risk individuals, specifically pregnant women, need to be targeted. Methods In semi-field conditions within a residential property in Cairns, Queensland, the impacts of metofluthrin on biting behaviour of free-flying Wolbachia-infected Ae. aegypti were evaluated. Results Mortality in Ae. aegypti exposed to metofluthrin over a 22 h period was 100% compared to 2.7% in an untreated room. No biting activity was observed in mosquitoes up to 5 m from the emanator after 10 min of metofluthrin exposure. Use of metofluthrin reduced biting activity up to 8 m, regardless of the host’s proximity (near or far) to a dark harbourage area (HA) (P < 0.0001 and P = 0.006), respectively. In the presence or absence of the metofluthrin emanator, the host was most likely bitten when located immediately next to a HA (within 1 m) versus 8 m away from the HA (P = 0.006). The addition of a ceiling fan (0.8 m/s airflow) prevented all biting activity after 10 min of metofluthrin exposure. Previously unexposed Ae. aegypti were less likely to reach the host in a metofluthrin-treated room ( X − $$\Big(\overset{-}{X}$$ = 31%) compared to an untreated room ( X − = 100 % $$\overset{-}{X}=100\%$$ ) (P < 0.0001). In a treated room, if the mosquito had not reached the host within 30 s, they never would. Upon activation, the time required for metofluthrin to infiltrate protected locations within a room causing knockdown in caged mosquitoes, required more time than exposed locations (P < 0.003); however exposed and protected locations do eventually reach equilibrium, affecting mosquitoes equally throughout the room. Conclusion Metofluthrin is effective in interrupting indoor host-seeking in Ae. aegypti. Metofluthrin’s efficacy is increased by centrally locating the emanator in the room, and by using a fan to increase airflow. Newly treated rooms may require a period of 2–4 h for sufficient distribution of the metofluthrin into protected locations where mosquitoes may be resting

Development, optimization, and field evaluation of the novel collapsible passive trap for collection of mosquitoes

Disease surveillance for mosquito-borne pathogens in remote areas can be challenging. Most traps used to collect mosquitoes either need a source of electricity or are bulky and inflexible, making transportation awkward. To reduce these issues we developed three Collapsible Passive Traps (CPTs) and conducted trials in Cairns, Australia to evaluate the optimal design for a CPT and compared them to traditionally-used traps such as Centers for Disease Control and Prevention (CDC) and Encephalitis Vector Surveillance (EVS) light traps. We found that two of the CPTs collected comparable numbers of mosquitoes and that one of the CPTs outperformed the CDC light trap in collecting Aedes species. Mosquitoes did not have to pass through a fan while entering the CPT, and thus were not damaged and were often alive. Our results suggest that the CPT can be an effective trap for mosquito surveillance, especially in remote areas

Field validation of the gravid Aedes trap (GAT) for collection of Aedes aegypti (Diptera: Culicidae)

Current surveillance methods for adult Aedes aegypti (L.) are expensive, require electrical power (e. g., the BG-Sentinel trap, BGS), are labor intensive (aspirators), or require difficult to use and costly adhesives (sticky ovitraps). Field trials were conducted in Cairns (Australia) to compare the efficacy of the newly designed Gravid Aedes Trap (GAT) against existing sticky ovitraps (MosquiTRAP and double sticky ovitrap) and the BGS. Latin square design trials confirmed that a large GAT using a 9.2-liters bucket treated with Mortein Barrier Outdoor Surface Spray ([ AI] 0.3 g/ kg imiprothrin and 0.6 g/ kg deltamethrin) outperformed a smaller 1.2-liters GAT and collected, on average, 3.7 X and 2.4 X more female Ae. aegypti than the MosquiTRAP and double sticky ovitrap, respectively. Field trials showed that the GAT collected 10-50% less female Ae. aegypti than the BGS trap but 30% more gravid mosquitoes than the BGS. Trials using the BGS and the GAT indicated that there was no difference in capture rates between female Ae. aegypti uninfected and infected with the wMel strain of Wolbachia, and wMel infection rates were nearly identical at > 90% to field captured Ae. aegypti. The potential for the GAT to be used for dengue virus surveillance was also demonstrated with dengue virus type 3RNAdetected in five-sixths and six-sixths pools of Ae. aegypti stored in a GAT held at 28 degrees C and 60% relative humidity for 7 and 14 d, respectively. Mosquito knock down in GATs treated with Mortein surface spray set in 30, 70, and 99% shade was comparable for up to 2 mo, with only similar to 10% of adults escaping. The GAT is therefore a useful tool for capturing adult Ae. aegypti and may be suitable for other container-inhabiting species such as Aedes albopictus (Skuse) and Culex quinquefasciatus Say. The low cost and practicality of operation make the GAT suitable for vector surveillance and projects requiring monitoring of mosquitoes for Wolbachia and arboviruses, especially in developing countries